It has been reported that the delivery of NRP1 via exosomes/sEVs from MDCK oncogenic cells to the surface of recipient endothelial cells leads to increased responsiveness to soluble angiogenic ligands such as VEGF-A, thereby activating tumor angiogenesis [28]. This evidence concerns the gene VEGFA and neoplasm.